AIM

AIM IMMUNOTECH INC

AIM·00901B303·US·Common Stock·Healthcare - Biotechnology-13D/G

AIM (AIM IMMUNOTECH INC) is held by 12 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($17,501), XTX Topco Ltd ($12,045), JANE STREET GROUP, LLC ($11,727). Net institutional sentiment: Bullish.

12
Holders
(1 Elite)
$55,007
Total Value
78% (9)
Consensus
7 buying - 2 selling
13F: Insider & Congress:
AIMSmart Money Verdict
View all
Held by 12 funds
1 elite
Who's Trading
ActivistMPMitchell P. Kopin0.0%May 27, 2026
ActivistOAOrca Capital AG9.9%May 12, 2026
InsiderEKEquels Thomas KBuy $823.58Jun 13, 2025
InsiderEKEquels Thomas KBuy $50KApr 11, 2025
InsiderKDKELLNER TED DBuy $50KApr 11, 2025
InsiderMMMITCHELL WILLIAM MBuy $5KApr 11, 2025
InsiderEKEquels Thomas KBuy $3KApr 4, 2025
InsiderRIRodino Peter W IIIBuy $43.5Apr 4, 2025
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
29,918(+72.2%)$17,5010.0%-84.28%
19
New
20,590$12,0450.0%-60.00%
24
New
20,047$11,7270.0%-60.00%
27
New
17,519$10,2490.0%-60.00%
26
New
5,000$2,9250.0%-60.00%
20
Unchanged
864$5050.0%-96.47%
0
New
50,895$300.0%-60.00%
15
New
26,032$150.0%-60.00%
17
Unchanged
15$70.0%-95.78%
0
Decreased
1(-99.7%)$10.0%-96.09%
0
Unchanged
1$10.0%-96.76%
0
Unchanged
2$10.0%-96.76%
0
Exited
0(-100.0%)$320.0%-80.95%
0

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used